Machinis Theofilos G, Fountas Kostas N, Dimopoulos Vassilios G, Troup E Christopher
Department of Neurosurgery, Medical Center of Central Georgia, Mercer University School of Medicine, Macon, GA, USA.
Childs Nerv Syst. 2006 Nov;22(11):1487-91. doi: 10.1007/s00381-006-0155-y. Epub 2006 Sep 8.
Posterior reversible encephalopathy syndrome (PRES) constitutes a well-described clinical entity, classically entailing characteristic edematous lesions on imaging studies in a patient with altered mental status, visual disturbances, headache, and seizures. PRES is reversible in the vast majority of cases, although progression to ischemia and hemorrhage has been documented.
We report a case of a 16-year-old male with chronic renal failure who developed PRES during a hypertensive crisis. The hypertension was successfully managed and PRES-associated symptomatology showed complete regression. However, approximately 2 months later, the patient returned with a spontaneous posterior fossa hemorrhage. Two weeks before this second admission, treatment with low-molecular weight heparin had been initiated. The patient finally succumbed, despite surgical evacuation. The pertinent literature is reviewed.
We suggest that the administration of low-molecular weight heparin in the setting of recent PRES might increase the risk for the development of intracranial hemorrhage.